Confidential treatment shall be requested as to portions marked "[Redacted]" pursuant to a request for confidential treatment to be filed with the Securities and Exchange Commission. Omitted portions shall be filed separately with the Securities and...Research Agreement • January 12th, 2006 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJanuary 12th, 2006 Company Industry JurisdictionThis AGREEMENT ("Agreement"), effective as of November __, 2005, ("Effective Date") is between THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, a New York corporation ("Columbia"), and MultiCell Technologies, Inc., a Delaware Corporation ("Company").
WORLDWIDE EXCLUSIVE LICENSE AGREEMENTWorldwide Exclusive License Agreement • January 12th, 2006 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledJanuary 12th, 2006 Company Industry JurisdictionThis License Agreement (the "Agreement") is made and entered into as of December 31, 2005 ("Effective Date") by and between Amarin Neuroscience Limited, a company organized under the laws of Scotland whose principal place of business is at Kings Park House, Laurehill Business Park, Polmaise Road, Stirling FK7 9JQ, Scotland, UK ("Amarin"), and Multicell Technologies, Inc., a corporation organized under the laws of the State of Delaware whose principal place of business is at 701 George Washington Highway, Lincoln, RI 02865 ("Multicell"). Amarin and Multicell are sometimes each hereinafter referred to as a "Party" or collectively as "Parties" to this Agreement.